SCHEMBL30450003

SCHEMBL30450003

C[C@H](COCc1nn(C)cc1Br)NC(=O)O

nearest known ligand 0.38

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ATM Q13315 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
ALDH1A1 P00352 2/20 0.36
RAB9A P51151 4/20 0.35
NPC1 O15118 3/20 0.35
KDM4E B2RXH2 2/20 0.35
TP53 P04637 1/20 0.35
HSD17B10 Q99714 1/20 0.35
SMN1; SMN2 Q16637 4/20 0.34
PKM P14618 2/20 0.34
GAA P10253 2/20 0.33
LMNA P02545 3/20 0.33
ALPL P05186 1/20 0.33
CYP1A2 P05177 1/20 0.32
CYP2C9 P11712 1/20 0.32
CYP2C19 P33261 1/20 0.32
MAPK1 P28482 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25826836 0.82 ALDH1A1 (0.32) ALDH1A1SMN1; SMN2
SCHEMBL25826829 0.82 ALDH1A1 (0.32) ALDH1A1SMN1; SMN2
SCHEMBL25826837 0.82 ALDH1A1 (0.32) ALDH1A1SMN1; SMN2
SCHEMBL31304946 0.78 ALDH1A1 (0.37) ATMNPSR1ALDH1A1RAB9ANPC1
SCHEMBL23850108 0.75 ALDH1A1 (0.38) ATMNPSR1ALDH1A1RAB9ANPC1
SCHEMBL31465655 0.72 NPSR1 (0.34) NPSR1ALDH1A1
SCHEMBL23850381 0.70 ROCK2 (0.44) ATMNPSR1ALDH1A1RAB9ANPC1
SCHEMBL21835462 0.70 SMN1; SMN2 (0.40) ATMNPSR1ALDH1A1RAB9ANPC1
SCHEMBL15883822 0.70 ALDH1A1 (0.35) ATMALDH1A1RAB9ANPC1KDM4E
SCHEMBL28918768 0.69 NPC1 (0.38) ATMNPSR1ALDH1A1RAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4460498-A1 MACROCYCLIC COMPOUNDS AND USE AS KINASE INHIBITORS Blossomhill Therapeutics, Inc. (US) 2024-11-13 EP disclosed
WO-2023133375-A1 MACROCYCLIC COMPOUNDS AND USE AS KINASE INHIBITORS BLOSSOMHILL THERAPEUTICS, INC. (US) 2023-07-13 WO disclosed